Many market players and researchers are developing new non-invasive ICP monitoring devices to expand their geographic reach and capacity to cater to many customers. In 2020, researchers developed a novel method for assessing intracranial pressure using non-invasive fundus images. The study focused on developing a novel, low-cost, fast, and easy measurement using noninvasive fundoscopy on non-dilated pupils to assess ICP using retinal A/V ratio. In this method, A/V-ratio decreased with ICP above 15 mmHg. The technique can potentially detect changes in ICP and possibly detect absolute ICP values. More research on this technique is needed to validate this. The ICP waveform obtained noninvasively through this system has the potential to widen the applicability and understanding of ICP in less explored clinical fields. NIRS has several advantages over other noninvasive methods such as low cost, bedside compatibility for long-term and continuous monitoring, along with user independence. Thus, growing research on non-invasive ICP monitoring devices is likely to drive growth of the market during the forecast period.
The South & Central America intracranial pressure (ICP) monitoring devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing import of medical devices, growing developments of healthcare systems that demand advanced medical technologies, and a rising geriatric population in the coming years.
South & Central America Intracranial Pressure Monitoring Devices Market Segmentation
The South & Central America intracranial pressure monitoring devices market is segmented into offering, type, application, end user, and country.
Based on offering, the South & Central America intracranial pressure monitoring devices market is segmented into product & systems, solutions & platform, and services. The products & systems segment held the largest share of the South & Central America intracranial pressure monitoring devices market in 2023.
Based on type, the South & Central America intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment held a larger share of the South & Central America intracranial pressure monitoring devices market in 2023.
Based on application, the South & Central America intracranial pressure monitoring devices market is segmented into traumatic brain injuries, Reye's syndrome, non-traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injuries segment held the largest share of the South & Central America intracranial pressure monitoring devices market in 2023.
Based on end user, the South & Central America intracranial pressure monitoring devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the South & Central America intracranial pressure monitoring devices market in 2023.
Based on country, the South & Central America intracranial pressure monitoring devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America intracranial pressure monitoring devices market in 2023.
RAUMEDIC AG, Integra LifeSciences Holdings Corp, Medtronic Plc, and Braincare Desenvolvimento e Inovacao Tecnologica SA are among the leading companies operating in the intracranial pressure monitoring devices market in South & Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 114.95 Million |
| Market Size by 2028 | US$ 160.15 Million |
| CAGR (2023 - 2028) | 6.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By Offering
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
1. Braincare Desenvolvimento e Inovacao Tecnologica SA
2. Integra LifeSciences Holdings Corp
3. Medtronic Plc
4. RAUMEDIC AG
The South & Central America Intracranial Pressure Monitoring Devices Market is valued at US$ 114.95 Million in 2023, it is projected to reach US$ 160.15 Million by 2028.
As per our report South & Central America Intracranial Pressure Monitoring Devices Market, the market size is valued at US$ 114.95 Million in 2023, projecting it to reach US$ 160.15 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.
The South & Central America Intracranial Pressure Monitoring Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Intracranial Pressure Monitoring Devices Market report:
The South & Central America Intracranial Pressure Monitoring Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Intracranial Pressure Monitoring Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Intracranial Pressure Monitoring Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)